ssociation of Codon 72 of P53 Gene Polymorphism with Chronic Hepatitis CVirus Infection: A Case Control Study

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 428

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JCMR-8-2_001

تاریخ نمایه سازی: 2 آبان 1396

Abstract:

Single nucleotide polymorphism in codon 72 of p53 gene (Arg/Pro) changes p53 protein structure and affects itsactivities. Hepatitis C virus (HCV) is believed to induce hepatocellular carcinoma and P53 polymorphisms have beenassociated with human cancers. The aim of this study was to evaluate genetic variants of codon 72 of p53 genepolymorphism in HCV patients and its relationship with HCV infection. The study was conducted on 67 HCVpatients, who were referred to medical centers of Mashhad city, Iran, and 73 healthy people from the same region.Genotyping of codon 72 of p53 gene was performed by PCR-RFLP method. The distributions of different alleles ofp53 polymorphisms did not differ significantly between groups. The respective proportions of Proline homozygotes,heterozygotes, and Arginine homozygotes were 37.31%, 35.82%, 26.86% in patients and 39.72%, 27.39%, and32.87% in the control group respectively. However, we found no significant differenece for the allelic or genotypedistribution between cases and controls. Our results indicated no strong evidence of association of the p53polymorphism with HCV infection; however, further investigation is needed in different ethnic groups to elucidatethe role of this polymorphism in HCV infection.

Authors

Sina Gerayli

Department of Biology, Western University, London, Ontario, N۶A ۵B۷, Canada

Alireza Pasdar

Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Sina Rostami

The Influenza Centre, Department of Clinical Science, University of Bergen, N-۵۰۲۱Bergen, Norway

Samaneh Sepahi

Targeted Drug Delivery Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran